Tapewire

Nasdaq · USD

TGTX

TG THERAPEUTICS, INC.

Export transactions ↓
Tapewire entity
3608
SEC CIK
0001001316
Parsed reports
111

Last 12 months

Inside the activity.

0 purchase rows · 2 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 10, 2026 Filed Sep 14, 2026 21:00 UTC SaleCommon Stock 5,000 $54.96 $274,800.00
Disclosure

SEC source: 0001437749-26-030343 · rdgdoc.xml · nonDerivative · entry 1

Charney Laurence N · CIK 0001407451 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 168,640

F1 · shares: These shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Charney's income tax obligations.

F2 · price: Price is the volume weighted average price of all transactions made by the Reporting Person on the transaction date for prices ranging from $54.92 to $54.99. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods.

Read SEC document
August 07, 2026 Filed Aug 7, 2026 21:00 UTC GiftCommon Stock 450 $0.00 $0.00
Disclosure

SEC source: 0001437749-26-026608 · rdgdoc.xml · nonDerivative · entry 3

Charney Laurence N · CIK 0001407451 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 173,640

F1 · shares: 1. Represents a bona fide gift by the Reporting Person to a 501(c)(3) institution. The Reporting Person does not retain any beneficial ownership or pecuniary interest over the shares of the Company's Common Stock after effecting the transaction.

F2 · balance_after: 2. Includes shares of restricted Common Stock, which vest over various time periods.

Read SEC document
August 07, 2026 Filed Aug 7, 2026 21:00 UTC GiftCommon Stock 500 $0.00 $0.00
Disclosure

SEC source: 0001437749-26-026608 · rdgdoc.xml · nonDerivative · entry 2

Charney Laurence N · CIK 0001407451 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 174,090

F1 · shares: 1. Represents a bona fide gift by the Reporting Person to a 501(c)(3) institution. The Reporting Person does not retain any beneficial ownership or pecuniary interest over the shares of the Company's Common Stock after effecting the transaction.

F2 · balance_after: 2. Includes shares of restricted Common Stock, which vest over various time periods.

Read SEC document
August 06, 2026 Filed Aug 7, 2026 21:00 UTC GiftCommon Stock 5,100 $0.00 $0.00
Disclosure

SEC source: 0001437749-26-026608 · rdgdoc.xml · nonDerivative · entry 1

Charney Laurence N · CIK 0001407451 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 174,590

F1 · shares: 1. Represents a bona fide gift by the Reporting Person to a 501(c)(3) institution. The Reporting Person does not retain any beneficial ownership or pecuniary interest over the shares of the Company's Common Stock after effecting the transaction.

F2 · balance_after: 2. Includes shares of restricted Common Stock, which vest over various time periods.

Read SEC document
June 11, 2026 Filed Jun 15, 2026 21:03 UTC
Lonial SagarDirector
GrantStock Tracking Unit · Derivative 8,325 $0.00 $0.00
Disclosure

SEC source: 0001437749-26-020679 · rdgdoc.xml · derivative · entry 1

Lonial Sagar · CIK 0001816609 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,325

Underlying: Common Stock · 8,325 shares

Expires not disclosed

F1 · derivative.exercise_price: Each stock tracking unit ("STU") represents a contingent right to receive either (determined at the sole discretion of the committee of the Board of Directors of the Issuer that administers the Issuer's 2022 Incentive Plan) (i) one share of the Issuer's common stock or (ii) a cash payment equal to the fair market value of one share of the Issuer's common stock, no later than thirty (30) days after the first anniversary of the date of grant.

F2 · derivative.exercise_date: Provided the Reporting Person remains in continuous service with the Issuer through the vesting date, the STUs shall vest upon the first anniversary of the date of grant.

F2 · derivative.expiration_date: Provided the Reporting Person remains in continuous service with the Issuer through the vesting date, the STUs shall vest upon the first anniversary of the date of grant.

Read SEC document
June 11, 2026 Filed Jun 15, 2026 21:02 UTC
HUME DANIELDirector
GrantStock Tracking Unit · Derivative 8,325 $0.00 $0.00
Disclosure

SEC source: 0001437749-26-020677 · rdgdoc.xml · derivative · entry 1

HUME DANIEL · CIK 0001645514 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,325

Underlying: Common Stock · 8,325 shares

Expires not disclosed

F1 · derivative.exercise_price: Each stock tracking unit ("STU") represents a contingent right to receive either (determined at the sole discretion of the committee of the Board of Directors of the Issuer that administers the Issuer's 2022 Incentive Plan) (i) one share of the Issuer's common stock or (ii) a cash payment equal to the fair market value of one share of the Issuer's common stock, no later than thirty (30) days after the first anniversary of the date of grant.

F2 · derivative.exercise_date: Provided the Reporting Person remains in continuous service with the Issuer through the vesting date, the STUs shall vest upon the first anniversary of the date of grant.

F2 · derivative.expiration_date: Provided the Reporting Person remains in continuous service with the Issuer through the vesting date, the STUs shall vest upon the first anniversary of the date of grant.

Read SEC document
June 11, 2026 Filed Jun 15, 2026 21:02 UTC GrantStock Tracking Unit · Derivative 8,325 $0.00 $0.00
Disclosure

SEC source: 0001437749-26-020676 · rdgdoc.xml · derivative · entry 1

Hoberman Kenneth · CIK 0001573722 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,325

Underlying: Common Stock · 8,325 shares

Expires not disclosed

F1 · derivative.exercise_price: Each stock tracking unit ("STU") represents a contingent right to receive either (determined at the sole discretion of the committee of the Board of Directors of the Issuer that administers the Issuer's 2022 Incentive Plan) (i) one share of the Issuer's common stock or (ii) a cash payment equal to the fair market value of one share of the Issuer's common stock, no later than thirty (30) days after the first anniversary of the date of grant.

F2 · derivative.exercise_date: Provided the Reporting Person remains in continuous service with the Issuer through the vesting date, the STUs shall vest upon the first anniversary of the date of grant.

F2 · derivative.expiration_date: Provided the Reporting Person remains in continuous service with the Issuer through the vesting date, the STUs shall vest upon the first anniversary of the date of grant.

Read SEC document
June 11, 2026 Filed Jun 15, 2026 21:01 UTC GrantStock Tracking Unit · Derivative 8,325 $0.00 $0.00
Disclosure

SEC source: 0001437749-26-020675 · rdgdoc.xml · derivative · entry 1

Echelard Yann · CIK 0001561958 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,325

Underlying: Common Stock · 8,325 shares

Expires not disclosed

F1 · derivative.exercise_price: Each stock tracking unit ("STU") represents a contingent right to receive either (determined at the sole discretion of the committee of the Board of Directors of the Issuer that administers the Issuer's 2022 Incentive Plan) (i) one share of the Issuer's common stock or (ii) a cash payment equal to the fair market value of one share of the Issuer's common stock, no later than thirty (30) days after the first anniversary of the date of grant.

F2 · derivative.exercise_date: Provided the Reporting Person remains in continuous service with the Issuer through the vesting date, the STUs shall vest upon the first anniversary of the date of grant.

F2 · derivative.expiration_date: Provided the Reporting Person remains in continuous service with the Issuer through the vesting date, the STUs shall vest upon the first anniversary of the date of grant.

Read SEC document
June 11, 2026 Filed Jun 15, 2026 21:00 UTC GrantStock Tracking Unit · Derivative 8,325 $0.00 $0.00
Disclosure

SEC source: 0001437749-26-020673 · rdgdoc.xml · derivative · entry 1

Charney Laurence N · CIK 0001407451 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,325

Underlying: Common Stock · 8,325 shares

Expires not disclosed

F1 · derivative.exercise_price: Each stock tracking unit ("STU") represents a contingent right to receive either (determined at the sole discretion of the committee of the Board of Directors of the Issuer that administers the Issuer's 2022 Incentive Plan) (i) one share of the Issuer's common stock or (ii) a cash payment equal to the fair market value of one share of the Issuer's common stock, no later than thirty (30) days after the first anniversary of the date of grant.

F2 · derivative.exercise_date: Provided the Reporting Person remains in continuous service with the Issuer through the Vesting Date, the STUs shall vest upon the first anniversary of the date of grant.

F2 · derivative.expiration_date: Provided the Reporting Person remains in continuous service with the Issuer through the Vesting Date, the STUs shall vest upon the first anniversary of the date of grant.

Read SEC document
January 29, 2026 Filed Jan 29, 2026 22:24 UTC GiftCommon Stock 13,197 $0.00 $0.00
Disclosure

SEC source: 0001437749-26-002439 · rdgdoc.xml · nonDerivative · entry 2

Charney Laurence N · CIK 0001407451 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 179,690

F1 · shares: Represents a bona fide gift by the Reporting Person to the Reporting Person's children. The Reporting Person does not retain any beneficial ownership or pecuniary interest over the shares of the Company's Common Stock after effecting the transaction.

F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods.

Read SEC document
January 28, 2026 Filed Jan 29, 2026 22:24 UTC GiftCommon Stock 30,000 $0.00 $0.00
Disclosure

SEC source: 0001437749-26-002439 · rdgdoc.xml · nonDerivative · entry 1

Charney Laurence N · CIK 0001407451 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 192,887

F1 · shares: Represents a bona fide gift by the Reporting Person to the Reporting Person's children. The Reporting Person does not retain any beneficial ownership or pecuniary interest over the shares of the Company's Common Stock after effecting the transaction.

F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods.

Read SEC document
January 08, 2026 Filed Jan 9, 2026 22:16 UTC
WEISS MICHAEL SDirector · CEO
GrantCommon Stock 622,000 $0.00 $0.00
Disclosure

SEC source: 0001437749-26-001016 · rdgdoc.xml · nonDerivative · entry 1

WEISS MICHAEL S · CIK 0001038977 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,778,086

F1 · shares: Reflects a grant of restricted shares, all of which will vest on the first anniversary of the date on which the first of any of the following occur: (i) the Company's total shareholder return (TSR) exceeds the TSR of the Nasdaq Biotechnology Index (NBI) over a 3-year period; (ii) the Company's TSR exceeds the TSR of the NBI over a 5-year period; (iii) the Company's TSR exceeds the TSR of the NBI over a 7-year period; or (iv) the Company's TSR exceeds the TSR of the NBI over a 9-year period.

F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods.

Read SEC document
January 08, 2026 Filed Jan 9, 2026 22:15 UTC GrantCommon Stock 90,000 $0.00 $0.00
Disclosure

SEC source: 0001437749-26-001015 · rdgdoc.xml · nonDerivative · entry 1

Power Sean A · CIK 0001538845 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 798,111

F1 · shares: Reflects a grant of restricted shares, of which 1/4 will vest equally on 1/1/27, 1/1/28, 1/1/29, and 1/1/30.

F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods.

Read SEC document
November 24, 2025 Filed Nov 25, 2025 22:31 UTC SaleCommon Stock 5,000 $32.57 $162,850.00
Disclosure

SEC source: 0001437749-25-036358 · rdgdoc.xml · nonDerivative · entry 1

Echelard Yann · CIK 0001561958 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 223,816

F1 · shares: These shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Echelard's income tax obligations.

F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods.

Read SEC document
November 05, 2025 Filed Nov 7, 2025 22:01 UTC
WEISS MICHAEL SDirector · CEO
GiftCommon Stock 803,717 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-033888 · rdgdoc.xml · nonDerivative · entry 2

WEISS MICHAEL S · CIK 0001038977 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,156,086

F3 · shares: Represents the transfer of shares to The Weiss Family and Descendants Trust.

F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods.

Read SEC document
November 05, 2025 Filed Nov 7, 2025 22:01 UTC
WEISS MICHAEL SDirector · CEO
GiftCommon Stock 3,865,126 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-033888 · rdgdoc.xml · nonDerivative · entry 1

WEISS MICHAEL S · CIK 0001038977 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,959,803

F1 · shares: Represents distribution of shares upon termination of the Michael Sean Weiss 2022 Grantor Retained Annuity Trust to irrevocable trusts for the benefit of Mr. Weiss' children.

F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods.

Read SEC document
September 11, 2025 Filed Sep 12, 2025 20:42 UTC
Lonial SagarDirector
SaleCommon Stock 20,852 $32.24 $672,268.48
Disclosure

SEC source: 0001437749-25-028952 · rdgdoc.xml · nonDerivative · entry 1

Lonial Sagar · CIK 0001816609 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,061

F1 · shares: These shares were sold by the Company's restricted stock administrator in order to satisfy the Reporting Person's income tax obligations.

F2 · price: Price is the volume weighted average price of all transactions made by the Reporting Person on the transaction date for prices ranging from $32.22 to $32.30. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods.

Read SEC document
June 13, 2025 Filed Jun 16, 2025 21:47 UTC SaleCommon Stock 10,000 $36.94 $369,400.00
Disclosure

SEC source: 0001437749-25-020546 · rdgdoc.xml · nonDerivative · entry 2

Echelard Yann · CIK 0001561958 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 228,816

F3 · shares: These shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Echelard's income tax obligations.

F4 · price: Includes a weighted average price for shares sold in multiple transactions at prices ranging from $36.93 through $36.96, inclusive. Mr. Echelard undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods.

Read SEC document
June 12, 2025 Filed Jun 16, 2025 21:45 UTC
Lonial SagarDirector
GrantCommon Stock 14,718 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-020540 · rdgdoc.xml · nonDerivative · entry 1

Lonial Sagar · CIK 0001816609 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 114,913

F1 · shares: Reflects a grant of restricted shares that will vest on June 12, 2026.

F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods.

Read SEC document
June 12, 2025 Filed Jun 16, 2025 21:47 UTC GrantCommon Stock 14,718 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-020546 · rdgdoc.xml · nonDerivative · entry 1

Echelard Yann · CIK 0001561958 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 238,816

F1 · shares: Reflects a grant of restricted shares that will vest on June 12, 2026.

F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods.

Read SEC document
June 12, 2025 Filed Jun 16, 2025 21:47 UTC GrantCommon Stock 21,408 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-020545 · rdgdoc.xml · nonDerivative · entry 1

Charney Laurence N · CIK 0001407451 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 222,887

F1 · shares: Reflects a grant of restricted shares that will vest on June 12, 2026.

F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods.

Read SEC document
June 12, 2025 Filed Jun 16, 2025 21:46 UTC GrantCommon Stock 14,718 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-020543 · rdgdoc.xml · nonDerivative · entry 1

Hoberman Kenneth · CIK 0001573722 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 279,653

F1 · shares: Reflects a grant of restricted shares that will vest on June 12, 2026.

F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods.

Read SEC document
June 12, 2025 Filed Jun 16, 2025 21:45 UTC
HUME DANIELDirector
GrantCommon Stock 14,718 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-020541 · rdgdoc.xml · nonDerivative · entry 1

HUME DANIEL · CIK 0001645514 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 192,748

F1 · shares: Reflects a grant of restricted shares that will vest on June 12, 2026.

F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods.

Read SEC document
March 17, 2025 Filed Mar 18, 2025 21:01 UTC
HUME DANIELDirector
GiftCommon Stock 62,459 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-008284 · rdgdoc.xml · nonDerivative · entry 1

HUME DANIEL · CIK 0001645514 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 178,030

F1 · shares: Reflects the transfer of shares of TG Therapeutics stock to a trust for the benefit of Mr. Hume's dependents.

F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods.

Read SEC document
March 10, 2025 Filed Mar 11, 2025 21:00 UTC GiftCommon Stock 6,000 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-007052 · rdgdoc.xml · nonDerivative · entry 1

Charney Laurence N · CIK 0001407451 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 201,479

F1 · security: Reflects the transfer of shares as a bona fide gift to a 501(c)(3) charitable organization.

F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods.

Read SEC document
January 29, 2025 Filed Jan 30, 2025 22:17 UTC
WEISS MICHAEL SDirector · CEO
GrantCommon Stock 750,000 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-002292 · rdgdoc.xml · nonDerivative · entry 1

WEISS MICHAEL S · CIK 0001038977 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,824,929

F1 · shares: Reflects a grant of restricted shares, all of which will vest on the first anniversary of the date on which the first of any of the following occur: (i) the Company's total shareholder return (TSR) exceeds the TSR of the Nasdaq Biotechnology Index (NBI) over a 3-year period; (ii) the Company's TSR exceeds the TSR of the NBI over a 5-year period; (iii) the Company's TSR exceeds the TSR of the NBI over a 7-year period; or (iv) the Company's TSR exceeds the TSR of the NBI over a 9-year period.

F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods.

Read SEC document
January 29, 2025 Filed Jan 30, 2025 22:15 UTC GrantCommon Stock 87,500 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-002290 · rdgdoc.xml · nonDerivative · entry 1

Power Sean A · CIK 0001538845 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 708,111

F1 · shares: Reflects a grant of restricted shares, of which 1/4 will vest equally on 1/1/26, 1/1/27, 1/1/28, and 1/1/29.

F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods.

Read SEC document
January 06, 2025 Filed Jan 7, 2025 23:01 UTC SaleCommon Stock 10,021 $28.53 $285,939.21
Disclosure

SEC source: 0001437749-25-000662 · rdgdoc.xml · nonDerivative · entry 2

Power Sean A · CIK 0001538845 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 660,611

F1 · shares: In connection with the vesting of 45,000 shares on January 1, 2025, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Power's tax withholding obligations. Mr. Power had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock.

F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods.

Read SEC document
January 03, 2025 Filed Jan 7, 2025 23:01 UTC SaleCommon Stock 11,337 $30.29 $343,443.08
Disclosure

SEC source: 0001437749-25-000662 · rdgdoc.xml · nonDerivative · entry 1

Power Sean A · CIK 0001538845 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 670,632

F1 · shares: In connection with the vesting of 45,000 shares on January 1, 2025, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Power's tax withholding obligations. Mr. Power had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock.

F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods.

Read SEC document
November 12, 2024 Filed Nov 12, 2024 22:01 UTC GiftCommon Stock 5,000 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-034595 · rdgdoc.xml · nonDerivative · entry 2

Charney Laurence N · CIK 0001407451 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 207,479

F3 · security: Reflects the transfer of shares as a bona fide gift to a 501(c)(3) charitable organization.

F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods.

Read SEC document
November 11, 2024 Filed Nov 12, 2024 22:02 UTC
Lonial SagarDirector
SaleCommon Stock 5,000 $30.44 $152,200.00
Disclosure

SEC source: 0001437749-24-034597 · rdgdoc.xml · nonDerivative · entry 1

Lonial Sagar · CIK 0001816609 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,195

F1 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods.

Read SEC document
November 11, 2024 Filed Nov 12, 2024 22:01 UTC SaleCommon Stock 25,000 $30.20 $754,875.00
Disclosure

SEC source: 0001437749-24-034595 · rdgdoc.xml · nonDerivative · entry 1

Charney Laurence N · CIK 0001407451 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 212,479

F1 · price: Reflects the weighted average sale price. The range of prices for the shares sold was $30.17 to $30.29. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.

F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods.

Read SEC document
November 05, 2024 Filed Nov 7, 2024 21:35 UTC SaleCommon Stock 20,000 $24.48 $489,600.00
Disclosure

SEC source: 0001437749-24-033950 · rdgdoc.xml · nonDerivative · entry 1

Echelard Yann · CIK 0001561958 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 224,098

F1 · shares: These shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Echelard's income tax obligations.

F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods.

Read SEC document
June 20, 2024 Filed Jun 20, 2024 22:07 UTC
Lonial SagarDirector
SaleCommon Stock 16,348 $16.87 $275,790.76
Disclosure

SEC source: 0001437749-24-020851 · rdgdoc.xml · nonDerivative · entry 3

Lonial Sagar · CIK 0001816609 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 105,195

F1 · shares: These shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Lonial's income tax obligations.

F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods.

Read SEC document
June 19, 2024 Filed Jun 20, 2024 22:07 UTC
Lonial SagarDirector
GrantCommon Stock 22,250 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-020851 · rdgdoc.xml · nonDerivative · entry 2

Lonial Sagar · CIK 0001816609 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 121,543

F3 · shares: Reflects a grant of restricted shares that will vest on June 14, 2025.

F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods.

Read SEC document
June 19, 2024 Filed Jun 20, 2024 22:07 UTC
HUME DANIELDirector
GrantCommon Stock 22,250 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-020850 · rdgdoc.xml · nonDerivative · entry 1

HUME DANIEL · CIK 0001645514 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 240,489

F1 · shares: Reflects a grant of restricted shares that will vest on June 14, 2025.

F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods.

Read SEC document
June 19, 2024 Filed Jun 20, 2024 22:05 UTC GrantCommon Stock 22,250 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-020849 · rdgdoc.xml · nonDerivative · entry 1

Hoberman Kenneth · CIK 0001573722 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 264,935

F1 · shares: Reflects a grant of restricted shares that will vest on June 14, 2025.

F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods.

Read SEC document
June 19, 2024 Filed Jun 20, 2024 22:05 UTC GrantCommon Stock 22,250 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-020848 · rdgdoc.xml · nonDerivative · entry 1

Echelard Yann · CIK 0001561958 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 244,098

F1 · shares: Reflects a grant of restricted shares that will vest on June 14, 2025.

F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods.

Read SEC document
June 19, 2024 Filed Jun 20, 2024 22:04 UTC GrantCommon Stock 22,250 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-020847 · rdgdoc.xml · nonDerivative · entry 1

Charney Laurence N · CIK 0001407451 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 237,479

F1 · shares: Reflects a grant of restricted shares that will vest on June 14, 2025.

F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods.

Read SEC document
June 17, 2024 Filed Jun 20, 2024 22:07 UTC
Lonial SagarDirector
SaleCommon Stock 9,585 $16.39 $157,098.15
Disclosure

SEC source: 0001437749-24-020851 · rdgdoc.xml · nonDerivative · entry 1

Lonial Sagar · CIK 0001816609 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 99,293

F1 · shares: These shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Lonial's income tax obligations.

F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods.

Read SEC document
March 13, 2024 Filed Mar 15, 2024 20:37 UTC
Lonial SagarDirector
SaleCommon Stock 5,000 $15.94 $79,675.00
Disclosure

SEC source: 0001437749-24-008124 · rdgdoc.xml · nonDerivative · entry 1

Lonial Sagar · CIK 0001816609 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 108,878

F1 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods.

Read SEC document
March 12, 2024 Filed Mar 13, 2024 20:52 UTC SaleCommon Stock 22,000 $15.97 $351,340.00
Disclosure

SEC source: 0001437749-24-007662 · rdgdoc.xml · nonDerivative · entry 1

Charney Laurence N · CIK 0001407451 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 215,229

F1 · shares: These shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Charney's income tax obligations.

F2 · price: Reflects the weighted average sale price. The range of prices for the shares sold was $15.95 to $16.00. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods.

Read SEC document
January 06, 2024 Filed Jan 8, 2024 23:32 UTC GrantCommon Stock 1,001,908 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-000899 · rdgdoc.xml · nonDerivative · entry 1

WEISS MICHAEL S · CIK 0001038977 · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,074,929

F1 · shares: Reflects a grant of restricted shares, which will vest and become non-forfeitable based on the Company's total shareholder return relative to the Nasdaq Biotechnology Index over a one-year to five-year period, provided that the Reporting Person remains an employee, director and/or consultant of the Company through each vesting date.

F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods.

Read SEC document
January 05, 2024 Filed Jan 5, 2024 22:00 UTC GrantCommon Stock 75,000 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-000756 · rdgdoc.xml · nonDerivative · entry 2

Power Sean A · CIK 0001538845 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 681,969

F3 · shares: Reflects a grant of restricted shares, of which 1/4 will vest on 1/1/2025, 1/4 will vest on 1/1/2026, 1/4 will vest on 1/1/2027, and 1/4 will vest on 1/1/2028.

F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods.

Read SEC document
January 05, 2024 Filed Jan 8, 2024 23:33 UTC SaleCommon Stock 17,500 $19.03 $333,025.00
Disclosure

SEC source: 0001437749-24-000900 · rdgdoc.xml · nonDerivative · entry 1

Charney Laurence N · CIK 0001407451 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 237,229

F1 · shares: In connection with the vesting of 58,732 shares on January 4, 2024, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Charney's income tax obligations. Mr. Charney had no discretion with respect to such sale, which was transacted in accordance with the Company's corporate policies regarding the vesting of restricted stock.

F2 · price: Reflects the weighted average sale price. The range of prices for the shares sold was $19.01 to $19.06. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods.

Read SEC document
January 03, 2024 Filed Jan 5, 2024 22:00 UTC SaleCommon Stock 47,867 $16.91 $809,430.97
Disclosure

SEC source: 0001437749-24-000756 · rdgdoc.xml · nonDerivative · entry 1

Power Sean A · CIK 0001538845 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 606,969

F1 · shares: In connection with the vesting of 95,000 shares on January 1, 2024, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Power's tax withholding obligations. Mr. Power had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock.

F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods.

Read SEC document
December 15, 2023 Filed Feb 15, 2024 02:53 UTC GiftCommon Stock 40,000 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-004259 · rdgdoc.xml · nonDerivative · entry 1

Power Sean A · CIK 0001538845 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 641,969

F1 · security: Reflects the transfer of shares of TG Therapeutics stock to the Power Family and Descendants Trust.

Read SEC document
September 28, 2023 Filed Sep 29, 2023 21:02 UTC
Lonial SagarDirector
GrantCommon Stock 20,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-23-105403 · tm2327273-5_4seq1.xml · nonDerivative · entry 1

Lonial Sagar · CIK 0001816609 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 113,878

F1 · shares: Reflects a grant of restricted shares that will vest on June 14, 2024.

F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods.

Read SEC document
September 28, 2023 Filed Sep 29, 2023 21:01 UTC
HUME DANIELDirector
GrantCommon Stock 20,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-23-105400 · tm2327273-4_4seq1.xml · nonDerivative · entry 1

HUME DANIEL · CIK 0001645514 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 218,239

F1 · shares: Reflects a grant of restricted shares that will vest on June 14, 2024.

F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods.

Read SEC document
September 28, 2023 Filed Sep 29, 2023 21:01 UTC GrantCommon Stock 20,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-23-105394 · tm2327273-3_4seq1.xml · nonDerivative · entry 1

Hoberman Kenneth · CIK 0001573722 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 242,685

F1 · shares: Reflects a grant of restricted shares that will vest on June 14, 2024.

F2 · balance_after: Includes shares of restricted Common Stock, which vest over various time periods.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.